Pharming Group (PHGUF) Stock Statistics & Valuation Metrics

Pharming Group has a market cap or net worth of $691.63M. The enterprise value is $862.62M.

Pharming Group has 685,147,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharming Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -3.37%.

The current PE Ratio of Pharming Group is -59.89. Pharming Group’s PEG ratio is 1.11.

In the last 12 months, Pharming Group had revenue of 274.76M and earned -10.64M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 6.13M and capital expenditures -1.00M, giving a free cash flow of 5.13M billion.

Pharming Group pays an annual dividend of ―, resulting in a dividend yield of ―

Pharming Group upcoming earnings date is Jul 31, 2025, Before Open (Confirmed).

Pharming Group as a current ratio of 3.65, with Debt / Equity ratio of 55.67%

In the past 12 months, Pharming Group has paid 2.43M in taxes.

Pharming Group EV to EBITDA ratio is 52.58, with an EV/FCF ratio of -267.42.

Pharming Group has $107.27M in cash and marketable securities with $119.14M in debt, giving a net cash position of $11.87M billion.

Gross margin is 88.98%, with operating margin of -3.03%, and net profit margin of -3.87%.

The average price target for Pharming Group is $1.17, which is 11.43% higher than the current price. The consensus rating is Hold